Posted on August 18th, 2009 in Swine Flu
With two forms of influenza vaccine, BioCryst Pharma has the potential to emerge as one of the world’s top biotech companies in the fight against the swine flu. BioCryst stock has increase 450% since April 2009 reaching the best swine flu stock performed: Novavax NVAX with a 500% plus during the same period.
Tags: Avi biopharma, avii, BioCryst Peramivir, BioCryst Pharma, BioCryst Pharmaceuticals, BioCryst Pharmaceuticals Inc., BioCryst Pharmaceuticals Swine Flu, BioCryst Stock, BioCryst stock price, fluzone, influenza treatments, Novavax, NVAX, peramivir, pharmaceutical company, relenza, Shionogi, Sinovac Biotech, stocks to watch, SVA, Swine flu stocks, swine flu stocks to watch, swine flu symptoms, tamiflu, The swine flu, top biotech companies, Top Pharmaceutical, top pharmaceutical company